Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (KNSA)

Kiniksa Pharmaceuticals International Plc is a biotechnology company focused on developing innovative therapies for autoimmune and rare diseases

The company is engaged in advancing its pipeline of novel product candidates that target critical unmet medical needs, leveraging its expertise in immunology and inflammation. Kiniksa aims to bring effective treatments to patients through rigorous research and developmental strategies, seeking to improve the quality of life for individuals affected by challenging health conditions.